Antibodies against factor VIII with modified glycosylation in the variable region

Details for Australian Patent Application No. 2004264265 (hide)

International Classifications

Event Publications

16 March 2006 PCT application entered the National Phase

PCT publication WO2005/016455 Priority application(s): WO2005/016455

17 September 2009 Application Accepted

Published as AU-B-2004264265

17 December 2009 Amendment Made

The nature of the amendment is: Amend the applicant name from D. Collen Research Foundation vzw to Life Sciences Research Partners

7 January 2010 Section 223 Application Allowed

Life Sciences Research Partners The time in which to comply with Section 6(c) has been extended to 23 Oct 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

21 January 2010 Standard Patent Sealed

2 February 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 14 Nov 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

1 March 2012 Assignment Registered

Life Sciences Research Partners The patent has been assigned to ThromboGenics NV

28 June 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 02 and 14 Nov 2011 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.